- Advertisement -

A Story of Perseverance: An Interview with Matthew Porteus

Matthew Porteus, MD, PhD, Stanford University Physician-scientist Matthew Porteus, MD, PhD, has been a mainstay in the genome editing field for more than two decades....

Menarini Group signs licensing deal with Insilico for promising cancer treatment

The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused...

Developing a highly predictive genetic risk score for type 1 diabetes

Paul Tran is working to develop a highly predictive genetic risk score that will tell parents whether their baby is at significant risk for...

New Link between Lymphoma Growth and Blood-Brain Barrier Discovered

Central nervous system (CNS) lymphoma is a rare non-Hodgkin lymphoma in which malignant B cells from lymph tissue form in the brain and/or spinal...

Breastmilk’s IgA Protects Preemies from Deadly Disease

It is well known that the incidence of necrotizing enterocolitis (NEC), a devastating disease that affects neonatal premature infants, is lower in infants that...

Neem compound gedunin shows promise against pancreatic cancer

Ramadevi Subramani Reddy, Ph.D., remembers the neem tree from her childhood in India - a plant her grandmother used to treat everything from fevers...

Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop Virus-Filtration System

Asahi Kasei Bioprocess will unveil its VANTIJ® SU-VFC benchtop at Bioprocess International (BPI) East in Boston this week. This new small-format system is designed...

GBI Biomanufacturing Set to Launch SmartScale GMP Solutions

CDMO GBI Biomanufacturing will announce the launch of its new SmartScale GMP Solutions platform at BioProcess International (BPI) East 2026. SmartScale is an accelerated,...

Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop Virus-Filtration System

Asahi Kasei Bioprocess will unveil its VANTIJ® SU-VFC benchtop at Bioprocess International (BPI) East in Boston this week. This new small-format system is designed...

GBI Biomanufacturing Set to Launch SmartScale GMP Solutions

CDMO GBI Biomanufacturing will announce the launch of its new SmartScale GMP Solutions platform at BioProcess International (BPI) East 2026. SmartScale is an accelerated,...

The Saga of Sickle Cell Disease

The approval in December 2023 of Casgevy and Lyfgenia marked a major milestone in the treatment of sickle cell disease (SCD). This genetic disease,...

more new items

Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop Virus-Filtration System

Asahi Kasei Bioprocess will unveil its VANTIJ® SU-VFC benchtop at Bioprocess International (BPI) East in Boston this week. This new small-format system is designed...

GBI Biomanufacturing Set to Launch SmartScale GMP Solutions

CDMO GBI Biomanufacturing will announce the launch of its new SmartScale GMP Solutions platform at BioProcess International (BPI) East 2026. SmartScale is an accelerated,...

The Saga of Sickle Cell Disease

The approval in December 2023 of Casgevy and Lyfgenia marked a major milestone in the treatment of sickle cell disease (SCD). This genetic disease,...